SAIPH

SAIPH (Société Arabe des Industries Pharmaceutiques) is a leading Tunisian pharmaceutical company and a major player in the drug manufacturing sector across the Maghreb and Sub-Saharan Africa. Established in 1992, the company produces a diverse portfolio of generic medicines, including essential treatments for cardiovascular diseases, diabetes, and infectious diseases. SAIPH operates advanced manufacturing complexes in Tunisia and has expanded its footprint with a production site in Côte d'Ivoire to serve the West African market. The company is also involved in strategic initiatives for regional health security, such as the local manufacturing of vaccines and sterile injectable products. Through partnerships with multinational firms and regional organizations, SAIPH continues to enhance access to affordable, high-quality healthcare solutions in the Arab and African regions.